Universe · entity
Prosight Management, LP
Institutional manager (13F) · CIK 1617201
13F holdings · as of 2026-03-31 · top 46 · reported portfolio $610M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | NEKTAR THERAPEUTICS | $53M | 735,000 |
| 2 | BOSTON SCIENTIFIC CORP | $50M | 795,547 |
| 3 | JANUX THERAPEUTICS INC | $49M | 3,550,000 |
| 4 | PROCEPT BIOROBOTICS CORP | $49M | 1,945,000 |
| 5 | GALAPAGOS NV | $47M | 1,550,000 |
| 6 | GENEDX HOLDINGS CORP | $34M | 523,463 |
| 7 | SHATTUCK LABS INC | $32M | 5,004,439 |
| 8 | ADC THERAPEUTICS SA | $31M | 8,300,000 |
| 9 | KURA ONCOLOGY INC | $27M | 3,356,700 |
| 10 | ALNYLAM PHARMACEUTICALS INC | $25M | 76,000 |
| 11 | MEIRAGTX HLDGS PLC | $23M | 2,629,971 |
| 12 | ALKERMES PLC | $18M | 513,632 |
| 13 | SYNDAX PHARMACEUTICALS INC | $18M | 770,000 |
| 14 | VEEVA SYS INC | $15M | 86,480 |
| 15 | ZYMEWORKS INC | $13M | 539,049 |
| 16 | CRINETICS PHARMACEUTICALS IN | $13M | 350,000 |
| 17 | ABIVAX SA | $12M | 105,000 |
| 18 | CONCENTRA GROUP HOLDINGS PAR | $11M | 505,822 |
| 19 | TERNS PHARMACEUTICALS INC | $11M | 202,300 |
| 20 | PHREESIA INC | $9M | 1,100,000 |
| 21 | ONKURE THERAPEUTICS INC | $9M | 2,154,381 |
| 22 | CORBUS PHARMACEUTICALS HLDGS | $7M | 697,108 |
| 23 | SCHRODINGER INC | $6M | 510,578 |
| 24 | EMERGENT BIOSOLUTIONS INC | $5M | 639,118 |
| 25 | ROIVANT SCIENCES LTD | $5M | 180,000 |
| 26 | ORTHOPEDIATRICS CORP | $5M | 302,399 |
| 27 | IMMUNOVANT INC | $4M | 175,825 |
| 28 | ICU MED INC | $4M | 27,450 |
| 29 | TECTONIC THERAPEUTIC INC | $2M | 79,872 |
| 30 | ROCKET PHARMACEUTICALS INC | $2M | 683,856 |
| 31 | UPSTREAM BIO INC | $2M | 241,123 |
| 32 | PLIANT THERAPEUTICS INC | $2M | 1,667,600 |
| 33 | OMEROS CORP | $2M | 174,800 |
| 34 | INTUITIVE SURGICAL INC | $2M | 4,000 |
| 35 | AN2 THERAPEUTICS INC | $2M | 515,754 |
| 36 | ADICET BIO INC | $2M | 250,244 |
| 37 | REGENXBIO INC | $2M | 200,000 |
| 38 | COYA THERAPEUTICS INC | $2M | 420,360 |
| 39 | VIKING THERAPEUTICS INC | $1M | 45,000 |
| 40 | IRHYTHM HOLDINGS INC | $1M | 10,000 |
| 41 | TRUEBLUE INC | $974k | 249,107 |
| 42 | IMMUNEERING CORP | $650k | 123,409 |
| 43 | PALVELLA THERAPEUTICS INC NE | $623k | 5,000 |
| 44 | NOVOCURE LTD | $549k | 50,400 |
| 45 | REIN THERAPEUTICS INC | $535k | 411,600 |
| 46 | TRANSMEDICS GROUP INC | $497k | 5,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.